Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

BACKGROUND: We aimed to examine the safety and efficacy of bevacizumab and carboplatin in patients with breast cancer brain metastases. METHODS: We enrolled patients with breast cancer and > 1 measurable new or progressive brain metastasis. Patients received bevacizumab 15 mg/kg intravenously (IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Jose Pablo, Emblem, Kyrre E., Weitz, Michelle, Gelman, Rebecca S., Schneider, Bryan P., Freedman, Rachel A., Younger, Jerry, Pinho, Marco C., Sorensen, A. Gregory, Gerstner, Elizabeth R., Harris, Gordon, Krop, Ian E., Morganstern, Daniel, Sohl, Jessica, Hu, Jiani, Kasparian, Elizabeth, Winer, Eric P., Lin, Nancy U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706261/
https://www.ncbi.nlm.nih.gov/pubmed/33256829
http://dx.doi.org/10.1186/s13058-020-01372-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706261/
https://www.ncbi.nlm.nih.gov/pubmed/33256829
http://dx.doi.org/10.1186/s13058-020-01372-w

Ejemplares similares